PT - JOURNAL ARTICLE AU - Mizuki, Kazuyoshi AU - Okawara, Makoto AU - Hino, Ayako AU - Ando, Hajime AU - Nagata, Tomohisa AU - Tateishi, Seiichiro AU - Tsuji, Mayumi AU - Matsuda, Shinya AU - Fujino, Yoshihisa AU - , TI - Association between work attendance when experiencing fever or cold symptoms and company characteristics and socioeconomic status in the COVID-19 pandemic in Japanese workers: a cross-sectional study AID - 10.1101/2021.09.13.21263476 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.13.21263476 4099 - http://medrxiv.org/content/early/2021/09/15/2021.09.13.21263476.short 4100 - http://medrxiv.org/content/early/2021/09/15/2021.09.13.21263476.full AB - Objective This study investigated the association between attending work while experiencing fever or cold symptoms and workers’ socioeconomic background and company characteristics during the COVID-19 pandemic.Methods A cross-sectional online survey was performed. Of a total of 33,302 participants, 3,676 workers who experienced fever or cold symptoms after April 2020 were included. The odds ratios (ORs) of attending work while sick associated with workers’ socioeconomic background and company characteristics were evaluated using a multilevel logistic model.Results The OR of attending work while sick associated with a lack of policy prohibiting workers from working when ill was 2.75 (95%CI: 2.28–3.20, P<0.001).Conclusion This study suggests that clear company policies on work and illness can be effective for preventing employees from attending work while sick.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported and partly funded by the research grant from the University of Occupational and Environmental Health, Japan (no grant number); Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004); Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), and Hitachi Systems, Ltd. (no grant number) and scholarship donations from Chugai Pharmaceutical Co., Ltd. (no grant number)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan (reference No. R2-079 and R3-006).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to ethical restrictions